用于检测有问题的阿片类药物使用的筛查工具及其在社区药房实践中的潜在应用:综述。

IF 2.1 Q3 PHARMACOLOGY & PHARMACY
Integrated Pharmacy Research and Practice Pub Date : 2019-07-19 eCollection Date: 2019-01-01 DOI:10.2147/IPRP.S185663
Bryn Lindley, Nicholas Cox, Gerald Cochran
{"title":"用于检测有问题的阿片类药物使用的筛查工具及其在社区药房实践中的潜在应用:综述。","authors":"Bryn Lindley,&nbsp;Nicholas Cox,&nbsp;Gerald Cochran","doi":"10.2147/IPRP.S185663","DOIUrl":null,"url":null,"abstract":"<p><p>Problematic opioid use, constituted by a myriad of conditions ranging from misuse to use disorders, has continued to receive an increasing amount of attention in recent years resulting from the high use of opioids in the United States coinciding with morbidity and mortality. Deaths from drug overdoses increased by over 11% between 2014 and 2015, which supports the need for identification of problematic opioid use in additional health care settings. One of these settings is community pharmacy. The community pharmacy is a unique health service setting to identify and potentially intervene with patients at risk of or exhibit problematic opioid use. Problematic opioid use can be identified using one of the various screening tools in conjunction with evaluating prescription drug monitoring systems. A total of 12 tools were identified that could be employed in community pharmacy settings for identifying problematic opioid use. This review highlights these tools and strategies for use that can be utilized in the community pharmacy, which should be adapted to individual pharmacy settings and local needs. Future research should assess pharmacy personnel's knowledge and perceptions of problematic opioid use and associated screening tools and interventions, which tools can be most effectively used in a community pharmacy, workflow needs to implement problematic opioid use screenings, and the impact of pharmacist engagement in problematic opioid use screening on patient clinical outcomes.</p>","PeriodicalId":45655,"journal":{"name":"Integrated Pharmacy Research and Practice","volume":null,"pages":null},"PeriodicalIF":2.1000,"publicationDate":"2019-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/IPRP.S185663","citationCount":"14","resultStr":"{\"title\":\"Screening tools for detecting problematic opioid use and potential application to community pharmacy practice: a review.\",\"authors\":\"Bryn Lindley,&nbsp;Nicholas Cox,&nbsp;Gerald Cochran\",\"doi\":\"10.2147/IPRP.S185663\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Problematic opioid use, constituted by a myriad of conditions ranging from misuse to use disorders, has continued to receive an increasing amount of attention in recent years resulting from the high use of opioids in the United States coinciding with morbidity and mortality. Deaths from drug overdoses increased by over 11% between 2014 and 2015, which supports the need for identification of problematic opioid use in additional health care settings. One of these settings is community pharmacy. The community pharmacy is a unique health service setting to identify and potentially intervene with patients at risk of or exhibit problematic opioid use. Problematic opioid use can be identified using one of the various screening tools in conjunction with evaluating prescription drug monitoring systems. A total of 12 tools were identified that could be employed in community pharmacy settings for identifying problematic opioid use. This review highlights these tools and strategies for use that can be utilized in the community pharmacy, which should be adapted to individual pharmacy settings and local needs. Future research should assess pharmacy personnel's knowledge and perceptions of problematic opioid use and associated screening tools and interventions, which tools can be most effectively used in a community pharmacy, workflow needs to implement problematic opioid use screenings, and the impact of pharmacist engagement in problematic opioid use screening on patient clinical outcomes.</p>\",\"PeriodicalId\":45655,\"journal\":{\"name\":\"Integrated Pharmacy Research and Practice\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2019-07-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2147/IPRP.S185663\",\"citationCount\":\"14\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Integrated Pharmacy Research and Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2147/IPRP.S185663\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2019/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Integrated Pharmacy Research and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/IPRP.S185663","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 14

摘要

有问题的阿片类药物使用由从滥用到使用障碍等多种情况构成,近年来,由于美国阿片类物质的大量使用与发病率和死亡率同时发生,阿片类化合物的使用继续受到越来越多的关注。2014年至2015年间,药物过量导致的死亡人数增加了11%以上,这支持了在额外的医疗保健环境中识别有问题的阿片类药物使用的必要性。社区药房就是其中之一。社区药房是一个独特的医疗服务环境,用于识别有阿片类药物使用风险或表现出阿片类物质使用问题的患者,并可能对其进行干预。有问题的阿片类药物使用可以通过使用各种筛查工具之一结合评估处方药监测系统来确定。共确定了12种工具,可在社区药房环境中用于识别有问题的阿片类药物使用。这篇综述强调了这些可用于社区药房的工具和策略,这些工具和策略应适应个人药房设置和当地需求。未来的研究应评估药房人员对有问题的阿片类药物使用的知识和看法,以及相关的筛查工具和干预措施,哪些工具可以在社区药房中最有效地使用,实施有问题阿片类物质使用筛查的工作流程需要,以及药剂师参与有问题阿片类药物使用筛查对患者临床结果的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Screening tools for detecting problematic opioid use and potential application to community pharmacy practice: a review.

Problematic opioid use, constituted by a myriad of conditions ranging from misuse to use disorders, has continued to receive an increasing amount of attention in recent years resulting from the high use of opioids in the United States coinciding with morbidity and mortality. Deaths from drug overdoses increased by over 11% between 2014 and 2015, which supports the need for identification of problematic opioid use in additional health care settings. One of these settings is community pharmacy. The community pharmacy is a unique health service setting to identify and potentially intervene with patients at risk of or exhibit problematic opioid use. Problematic opioid use can be identified using one of the various screening tools in conjunction with evaluating prescription drug monitoring systems. A total of 12 tools were identified that could be employed in community pharmacy settings for identifying problematic opioid use. This review highlights these tools and strategies for use that can be utilized in the community pharmacy, which should be adapted to individual pharmacy settings and local needs. Future research should assess pharmacy personnel's knowledge and perceptions of problematic opioid use and associated screening tools and interventions, which tools can be most effectively used in a community pharmacy, workflow needs to implement problematic opioid use screenings, and the impact of pharmacist engagement in problematic opioid use screening on patient clinical outcomes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
3.40%
发文量
29
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信